Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, 601 N Caroline St / JHOC 3235, Baltimore, MD 21287, USA.
AJR Am J Roentgenol. 2013 Aug;201(2):W215-26. doi: 10.2214/AJR.13.10572.
OBJECTIVE. FDG PET/CT is emerging as an important modality in the evaluation of pleural tumors. PET/CT has an established role in the diagnosis and staging and shows promise in therapy planning, therapy response assessment, and providing prognostic information in patients with malignant pleural mesothelioma. This modality has distinct advantages in characterizing other primary pleural tumors and pleural metastases. CONCLUSION. FDG PET/CT is a useful imaging modality in the management of patients with primary pleural tumors and pleural metastases.
目的。FDG PET/CT 在胸膜肿瘤的评估中是一种新兴的重要手段。PET/CT 在诊断和分期方面具有既定的作用，并在治疗计划、治疗反应评估以及为恶性胸膜间皮瘤患者提供预后信息方面显示出前景。该方法在描述其他原发性胸膜肿瘤和胸膜转移方面具有明显的优势。结论。FDG PET/CT 是一种用于管理原发性胸膜肿瘤和胸膜转移患者的有用的成像方法。
